从COVID-19中恢复后的肺功能,焦虑,抑郁和睡眠质量
Somayeh Sadeghi1,2, Zary Nokhodian1, Shadi Reisizadeh Mobarakeh3
1Infectious Diseases and Tropical Medicine Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Tanaffos
|August 23, 2024
概括
许多COVID-19幸存者在康复后的几个月内经历了持续的症状和肺功能受损. 睡眠质量受到疾病严重程度的重大影响,突出了对COVID-19患者长期监测的必要性.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 精神病学是一个精神病学.
背景情况:
- 随着COVID-19的蔓延,它已经产生了全球性的影响.
- 康复的COVID-19患者的长期肺功能和生理变化需要进一步的文件.
- 了解COVID-19后的后果对于患者管理至关重要.
研究的目的:
- 在康复三个月后,评估COVID-19幸存者的肺功能,睡眠质量,焦虑和抑郁症.
- 根据COVID-19疾病严重程度来比较这些结果.
- 为了确定感染后的持续症状和功能障碍.
主要方法:
- 97名COVID-19患者 (门诊患者和住院患者) 的队列被跟踪了三个月.
- 进行了螺旋计 (FEV1,FVC,FEV1/FVC) 和6分钟步行测试 (6-MWT).
- 睡眠质量 (PSQI) 和情绪 (焦虑和抑郁的HADS) 被评估并在严重和非严重组之间进行比较.
主要成果:
- 超过70%的参与者在康复三个月后报告至少有一个持续的症状.
- 在严重和不严重的组之间没有发现螺旋计参数 (FVC,FEV1,FEV1/FVC) 或6-MWT的显著差异.
- 睡眠质量 (PSQI) 与疾病严重程度有显著的相关性 (P=0.031),而情绪 (HADS) 没有显著的影响 (P>0.05).
结论:
- 大部分COVID-19患者在康复三个月后表现出持续的症状和异常的肺功能测试.
- 疾病的严重程度显著影响COVID-19后的睡眠质量,这反过来又影响了情绪.
- 长期监测和管理COVID-19后果是必不可少的,无论最初的疾病严重程度如何.
相关概念视频
Other Pulmonary Disorders
808
Respiratory disorders encompass a range of conditions with varying levels of severity. Asthma, marked by chronic airway inflammation and hypersensitivity, is one such condition. It can lead to airway obstruction due to factors like bronchial spasms, mucosal edema, increased mucus secretion, or epithelial damage. Asthma triggers are diverse, ranging from allergens to emotional upset, and treatment focuses on both immediate relief through bronchodilators and long-term inflammation suppression.
808
Substance Use Disorders Affecting Sleep
163
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
163
Pneumonia II: Pathophysiology
236
The pathophysiology of pneumonia involves the following steps:
236
COPD: Management Using Bronchodilators and Corticosteroids
190
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
190
Asthma-III: Symptoms and Complications
2.5K
Asthma, a common chronic respiratory condition, is classified considering the frequency and severity of symptoms alongside lung function impairment. Understanding this classification is essential for appropriate treatment and management. Here's a detailed look at the classification of asthma and its clinical features and complications:
Classification of Asthma
Classification of Asthma
2.5K
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K


